# Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

> **NCT00383734** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 148 (actual)

## Conditions studied

- HIV-Associated Lipodystrophy Syndrome

## Interventions

- **DEVICE:** Newfill
- **DEVICE:** Eutrophill

## Key facts

- **NCT ID:** NCT00383734
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-09
- **Final completion:** 2010-09
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2011-12-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383734, "Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00383734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*